Simplex Trading
BHVN

Simplex Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Simplex Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,426
Closed -$656K – 11563
2022
Q2 		$644K Buy
4,426
+2,603
+143% +$332K ﹤0.01% 3151
2022
Q1 		$216K Buy
+1,823
New +$227K ﹤0.01% 5055
2021
Q1 		– Sell
-18,776
Closed -$1.52M – 10703
2020
Q4 		$1.61M Buy
18,776
+2,784
+17% +$236K ﹤0.01% 1999
2020
Q3 		$1.04M Buy
+15,992
New +$1.05M ﹤0.01% 2195
2020
Q2 		– Sell
-4,357
Closed -$232K – 8912
2020
Q1 		$148K Buy
+4,357
New +$199K ﹤0.01% 3937
2019
Q4 		– Sell
-18,374
Closed -$910K – 8515
2019
Q3 		$766K Sell
18,374
-36,060
-66% -$1.52M ﹤0.01% 2207
2019
Q2 		$2.38M Buy
54,434
+17,986
+49% +$1.01M 0.01% 1175
2019
Q1 		$1.88M Buy
36,448
+29,110
+397% +$1.26M 0.01% 1426
2018
Q4 		$271K Buy
7,338
+3,152
+75% +$114K ﹤0.01% 2825
2018
Q3 		$157K Buy
4,186
+1,232
+42% +$45.3K ﹤0.01% 3928
2018
Q2 		$116K Sell
2,954
-19,901
-87% -$631K ﹤0.01% 4119
2018
Q1 		$588K Buy
22,855
+20,449
+850% +$611K 0.03% 642
2017
Q4 		$64K Buy
+2,406
New +$66.2K ﹤0.01% 2213

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Simplex Trading's BHVN Position: Q3 2022 in Review

Simplex Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 4,426 shares — an estimated $656K sold.

Simplex Trading first reported a position in BHVN in Q4 2017 and held it in 13 quarters. The position peaked at $2.38M in Q2 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Simplex Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 4,426 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $656K.
  • Simplex Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2017 and held it in 13 quarters.
  • Simplex Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.38M in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.